CA2845673A1 - Compositions de nanoparticules pharmaceutiques - Google Patents

Compositions de nanoparticules pharmaceutiques Download PDF

Info

Publication number
CA2845673A1
CA2845673A1 CA2845673A CA2845673A CA2845673A1 CA 2845673 A1 CA2845673 A1 CA 2845673A1 CA 2845673 A CA2845673 A CA 2845673A CA 2845673 A CA2845673 A CA 2845673A CA 2845673 A1 CA2845673 A1 CA 2845673A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
nanoparticles
glaucoma
mifepristone
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2845673A
Other languages
English (en)
Inventor
Francesca CRAWFORD
Philip Gunning
David HERMANS
Deepak Thassu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALTACOR Ltd
Original Assignee
ALTACOR Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALTACOR Ltd filed Critical ALTACOR Ltd
Publication of CA2845673A1 publication Critical patent/CA2845673A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2845673A 2011-09-13 2012-09-13 Compositions de nanoparticules pharmaceutiques Abandoned CA2845673A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161534248P 2011-09-13 2011-09-13
US61/534,248 2011-09-13
PCT/GB2012/052272 WO2013038195A2 (fr) 2011-09-13 2012-09-13 Compositions de nanoparticules pharmaceutiques

Publications (1)

Publication Number Publication Date
CA2845673A1 true CA2845673A1 (fr) 2013-03-21

Family

ID=46889367

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2845673A Abandoned CA2845673A1 (fr) 2011-09-13 2012-09-13 Compositions de nanoparticules pharmaceutiques

Country Status (4)

Country Link
EP (1) EP2755659A2 (fr)
CN (1) CN103930115A (fr)
CA (1) CA2845673A1 (fr)
WO (1) WO2013038195A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017524712A (ja) 2014-08-13 2017-08-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 角膜同種移植片拒絶および新血管形成を予防するためのグルココルチコイドを負荷したナノ粒子
US11554126B2 (en) 2017-12-15 2023-01-17 Georgetown University Methods of treating residual lesions of vascular anomalies
US11878025B2 (en) * 2021-09-06 2024-01-23 Slayback Pharma Llc Pharmaceutical compositions of mifepristone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090798A (en) 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US7651694B2 (en) * 2004-02-13 2010-01-26 Nod Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of making and using same
AU2006282739A1 (en) 2005-08-25 2007-03-01 Psivida Us Inc. Control of induced elevated intraocular pressure
GB0601092D0 (en) 2006-01-19 2006-03-01 Daniolabs Ltd The Prevention Of Systemic Side-Effects Of Glucocorticoids
US20100105643A1 (en) * 2008-10-27 2010-04-29 Soll David B Ophthalmic composition
CA2782655A1 (fr) 2009-01-06 2010-07-15 Pharmanova, Inc. Preparations pharmaceutiques nanoparticulaires

Also Published As

Publication number Publication date
WO2013038195A3 (fr) 2013-07-04
WO2013038195A2 (fr) 2013-03-21
CN103930115A (zh) 2014-07-16
EP2755659A2 (fr) 2014-07-23

Similar Documents

Publication Publication Date Title
JP7368661B2 (ja) 医薬組成物
US11491240B2 (en) Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
AU2021203027B2 (en) Ophthalmic suspension composition
EP3843704B1 (fr) Formulations d'émulsion d'inhibiteurs de multikinase
US20080145430A1 (en) Ophthalmic Nanoparticulate Formulation Of A Cyclooxygenase-2 Selective Inhibitor
CN104350063A (zh) 疏水性治疗剂的制剂、其制备方法及应用
JP6487452B2 (ja) ブリンゾラミドを含む医薬組成物
CA2986297A1 (fr) Formation de nanoparticules de cyclosporine a/cyclodextrine
CA2845673A1 (fr) Compositions de nanoparticules pharmaceutiques
US20130316010A1 (en) Polymeric microparticles
WO2005018608A1 (fr) Systeme d'administration de produit pharmaceutique pour administrer de fins grains sous la capsule de tenon
CN114040766A (zh) 用于稳定包含药物的水性组合物pH的方法
EP3192510A1 (fr) Préparation de suspension pour instillation dans les yeux
US10973776B1 (en) Loteprednol etabonate nanoparticles in thermoreversible gels for enhanced therapeutics
JP2007056015A (ja) 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
EA041985B1 (ru) Офтальмологические микросуспензии на основе твердых циклодекстриновых комплексов дексаметазона, способы их получения и их применение

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150915